**Core tip:** Adenoma detection rate (ADR) is one of the most important quality measures in colonoscopy and bright narrow band imaging (bNBI) can theoretically improve imaging and thus reconnaissance of colorectal polyps. In addition, the magnification using bNBI with dual focus (bNBI-DF) allows the prediction of the polyp's histology. This multicenter randomised controlled trial was conceived to compare the ADR of high definition white light endoscopy (HD-WLE) vs bNBI during withdrawal of screening colonoscopies. No difference was found in ADR between HD-WLE and bNBI. The prediction of diminutive distal polyps with bNBI-DF was satisfactory according to the American Society for Gastrointestinal Endoscopy's threshold.

INTRODUCTION
============

Colorectal cancer is a leading cause of morbidity and mortality worldwide\[[@B1]\]. Its incidence in Asia-Pacific region has been rising at an alarming rate\[[@B2],[@B3]\]. Screening colonoscopy and polypectomy have been shown to reduce the mortality related to colorectal cancer\[[@B4]\]. Despite its effectiveness, the potential to miss polyps can range between 15% to 30% with screening colonoscopy\[[@B5]\]. Current guidelines recommend removal of all visible polyps (except benign diminutive distal polyps) and subjection to histological assessment, irrespective of their endoscopic morphological features. This could make colonoscopy a less cost effective screening strategy\[[@B6]\]. Novel image enhanced endoscopic technologies have the potential to overcome some of the limitations of standard while light endoscopy (WLE) by increasing the detection rate of polyps/neoplasms and providing real-time histological diagnosis.

Narrow band imaging (NBI) is one of the most widely available and convenient to use technologies developed. Narrowed bandwidth light is used to visualize superficial vasculature and mucosal pit patterns in real-time\[[@B7],[@B8]\]. The light penetrates the mucosa and submucosa and is absorbed by hemoglobin in surface microvessels, which appear as linear darker structures\[[@B9]\]. This enables the endoscopist to differentiate thicker and more irregular vascular landmarks. Multiple classification systems based on surface pit-pattern and vascular pattern have been developed and validated to differentiate hyperplastic polyps from adenomatous polyps\[[@B10],[@B11]\]. This real-time differentiation has been proposed as a part of "resect and discard" strategy in which diminutive polyps (measuring \< 5 mm) are resected without histological assessment and hyperplastic polyps in rectosigmoid region are left *in situ*\[[@B12]\]. This approach could confer substantial cost savings by avoiding unwarranted histological evaluation\[[@B13]\] and may avoid complications related to polypectomy\[[@B14]\]. Few published studies showed no significant difference in adenoma detection rates (ADRs) between NBI and WLE\[[@B15]-[@B18]\]. Only one meta-analysis demonstrated an increased accuracy of NBI over WLE in characterising colonic polyps with hierarchical summary receiver-operating characteristic curves exceeding 0.90\[[@B19]\]. Dimmer images compared to WLE\[[@B20]\], type of endoscopes and monitors used (high *vs* low resolution), inconsistent color enhancement settings and endoscopists' experience have been proposed as potential reasons for the unimpressive performance of NBI.

Recently, a newer generation NBI system has been introduced. The system appears to provide brighter NBI (bNBI) images (by 2 fold) in a high-definition (HD) mode and has the option of further magnifying a particular target with the dual focus (DF) magnification function, up to 65 times. These provide an in-depth view of desired areas of the mucosa with clear and crisp images, which potentially may improve polyp detection as well as characterisation.

In this study we hypothesized that, when compared to high definition white light endoscopy (HD-WLE), the newer generation colonoscopes with the brighter NBI capability and the bNBI with dual focus (bNBI-DF) magnification mode could improve ADR and accurately predict polyp histology.

MATERIALS AND METHODS
=====================

Study design
------------

We performed a prospective multicenter randomised controlled trial across four centers in the Asia Pacific region (The Prince of Wales Hospital, Hong Kong; The King Chulalongkorn Memorial Hospital, Thailand; Changi General Hospital, Singapore and The Lyell McEwin Hospital, Australia) from October 2010 to April 2012. Institutional medical and ethics committees of each participating hospital approved the study protocol. The study was registered with clinicaltrials.gov (NCT 01422577).

Study population
----------------

We recruited subjects who were referred for outpatient screening colonoscopy across four centers during the study period. All patients were 40 years and older with no significant medical comorbidities and met the criteria for average risk for the colorectal cancer with no previous colonoscopies in the last five years. Patients were excluded if they were on anti-platelets or anticoagulants, had any colorectal surgical resection, inflammatory bowel disease, familial colorectal cancer syndromes (familial adenomatous polyposis and hereditary non-polyposis colorectal cancer), were unable to provide written informed consent or had poor bowel preparation.

All participating subjects were informed about the study and written informed consent was obtained before initiation of the procedure. Participants were allowed to have clear fluids on the day before the procedure and were given four liters of polyethyleneglycol as bowel preparation followed by a 6-h fast (previous day preparation). Appropriate doses of conscious sedation (Fentanyl and Midazolam ± Propofol) were given prior to and during the procedure.

Eleven endoscopists participated in the study. Each of the endoscopists had extensive experience with the use of NBI in colonoscopy having performed more than 2000 procedures each using the earlier generation colonoscopes with NBI. The CF-HQ 190 or 290 series colonoscopes with the DF mode for magnification (Olympus, Tokyo Co. Ltd) were used for all patients. The colonoscope was connected to a CLV video processor with images transmitted to HD monitors (1280 × 1024 pixels). All participating endoscopists were consultants who had experience with an earlier generation of NBI scopes.

Randomisation
-------------

Subjects were randomised to receive the examination during withdrawal either in the HD-WLE or in the bNBI mode, followed by bNBI-DF to characterise each polyp that was identified in both arms (Figure [1](#F1){ref-type="fig"}). The colonoscope was inserted using HD-WLE until caecum was reached, in all subjects. Randomisation took place once the caecum or appendiceal orifice was identified and adequacy of bowel preparation was established as per the modified Aronchick scale\[[@B21]\]. Subjects with suboptimal bowel preparation were excluded. Patients were randomised according to a computer-generated randomisation scheme in blocks of twenty. Allocation to HD-WLE or bNBI mode of withdrawal was kept in a concealed envelope and revealed by a research assistant to the endoscopist just before withdrawal was initiated. A dedicated nurse assistant monitored both insertion (time to reach caecum from insertion) and withdrawal (time of scope removal from initiation of withdrawal) times with a stopwatch. During insertion, the stopwatch was paused during patient position change or while exerting abdominal pressure to facilitate colonoscope advancement. Similarly, the stopwatch was paused during withdrawal when biopsies or polypectomies were performed. The withdrawal time was set to a minimum of 6 min in both bNBI and HD-WLE arms and endoscopists were deliberately reminded of the time during the withdrawal phase.

![Study flow chart. bNBI: Bright narrow band imaging.](WJGE-9-273-g001){#F1}

Data collection
---------------

Colonoscope withdrawal commenced from the caecum with the patient in the left lateral position and was carried out according to randomisation. Location of each polyp was identified using anatomical landmarks and categorised into either the right or left side of the colon. The size of each polyp was assessed using diameter of the opened biopsy forceps (7.5 mm) or the diameter of the snare used. Identified polyps were characterised by using bNBI-DF mode in both arms.

Characterisation of polyps was made by bNBI-DF using Sano's classification, which has been found to be valid tool for predicting polyp histology\[[@B11]\]. The classification was based on vascular pattern on the surface of the polyp. Characterisation of polyps was made with high confidence if the polyp demonstrated endoscopic features, which were strongly suggestive of its pathology according to Sano's classification. Polyps were characterised with low confidence if exposure was limited secondary to non-removable debris, inadequate focus or if the polyp demonstrated features of more than one Sano's class.

The preferred mode of polypectomy was left to the endoscopists' discretion. Once the polypectomy was performed, mucosal viewing was switched back to respective mode as per randomisation. Each identified polyp was resected and retrieved into an individual container for pathologic examination. Pathologists with experience in gastrointestinal tract, who were blinded for the endoscopic mode of the examination, evaluated all resected polyps.

Outcomes
--------

The primary outcome of the study was to compare the ADR, defined as percentage of patients with one or more adenomatous polyp detected, between the two arms (HD-WLE *vs* bNBI). The secondary outcome was to assess if bNBI-DF could meet the American Society for Gastrointestinal Endoscopy (ASGE)'s Preservation and Incorporation of Valuable Endoscopic Innovation (PIVI) threshold in predicting histopathology of colon polyps\[[@B22]\]. We only assessed the second criteria from the PIVI guideline \[where the technology, when used with high confidence, should provide \> 90% negative predictive value (NPV) for adenomatous histology in diminutive rectosigmoid polyps\] as we believed that this strategy would be more practical and generalizable.

Sample size
-----------

We previously conducted a colonoscopy screening study amongst average risk Hong Kong Chinese subjects older than 50 years of age and found an ADR of 30%\[[@B23]\]. The prevalence of colon adenomas in asymptomatic subjects in Asia is unknown and is likely to vary across different ethnic groups. The sample size evaluation was based on assumption that improved optics and bNBI is superior to the HD-WLE mode in detection of colon polyps. We thus hypothesized that bNBI would be able to detect more adenomas than HD-WLE. A sample size of 500 per group was required to detect a relative risk of 1.28 (*i.e*., a difference of 38.4% *vs* 30%) with a power of 80% and a type 1 two-sided error of 0.05.

Statistical analysis
--------------------

Continuous variables were compared using the *t*-test if normally distributed. Categorical variables were compared using the χ^2^ test or Fisher's exact test when appropriate. The Mann-Whitney's *U* test was used for skewed variables. To compare the detection of all adenomas and hyperplastic polyps (per-polyp analysis), the Poisson regression model or negative binomial regression model was used. The accuracy of bNBI-DF in examining early colorectal lesions was evaluated using Sano's classification compared to the final histopathology and measures of sensitivity (Sn), specificity (Sp), positive predictive value (PPV), and NPV; and their correspondent 95%CIs were performed. These diagnostic tests were calculated by means of the generalized estimating equations to account for the clustering of polyps within patients.

In addition, we performed statistical analysis to examine the effect of the withdrawal time, entered as a covariate, on the ADR on a per-patient level. Specifically, a multiple logistic regression was used to estimate adjusted odds ratio (OR) and its 95%CI with all variables (see Table [1](#T1){ref-type="table"}) excluding time taken to reach cecum, entered as covariates. The presence or absence of one or more adenomas was considered a response variable. Mode of withdrawal (HD-WLE or bNBI) was forced to remain into all regression models. Two-tailed *P* value lower than 0.05 was considered statistically significant. Multiple outcomes were tested without adjusting for the type **I** error rate. Statistical tests were performed with the use of SPSS software (version 19.0, SPSS, Chicago, IL, United States).

###### 

Characteristics of patients and colonoscopy performance in both groups *n* (%)

  **Parameters**                       **bNBI (*n* = 495)**   **WLE (*n* = 511)**   ***P* value**
  ------------------------------------ ---------------------- --------------------- ---------------
  Patients                                                                          
  Men                                  210 (42.43)            237 (46.38)           0.207
  Age, mean ± SD                       58.31 ± 6.17           58.36 ± 6.13          0.904
  BMI, mean ± SD                       23.75 ± 3.29           23.74 ± 2.99          0.942
  Current smoker                       24 (4.9)               29 (5.7)              0.536
  Current drinker                      38 (7.7)               44 (8.7)              0.815
  Current use of NSAID                 6 (1.2)                9 (1.8)               0.705
  Current use of aspirin               13 (2.6)               22 (4.3)              0.345
  Current use of warfarin              0                      2 (0.4)               0.232
  Comorbidities                                                                     
  Hypertension                         123 (24.8)             131 (25.6)            0.774
  Diabetes                             56 (11.3)              32 (6.3)              0.005
  Ischemic heart disease               10 (2.0)               10 (2.0)              0.943
  Chronic obstructive airway disease   2 (0.4)                0                     0.15
  Previous stroke                      1 (0.2)                2 (0.4)               0.582
  Cirrhosis                            1 (0.2)                1 (0.2)               0.982
  Gastro-esophageal reflux             10 (2)                 8 (1.6)               0.587
  Dyslipidemia                         31 (6.3)               29 (5.7)              0.694
  History of cancer                    19 (3.8)               12 (2.3)              0.172
  Examination time (min), mean ± SD                                                 
  Time to cecum                        6.66 ± 4.56            7.06 ± 4.94           0.183
  Time for withdrawal                  11.23 ± 6.36           9.84 ± 5.03           \< 0.0001

bNBI: Bright narrow band imaging; WLE: White light endoscopy.

RESULTS
=======

A total of 1006 patients were enrolled during the 17-mo study period (October 2010 to April 2012), of which 44.4% were men and the mean age was 58 years. Four hundred and ninety-five participants were randomised to the bNBI arm and 511 participants to the HD-WLE arm. Table [1](#T1){ref-type="table"} demonstrates the demographics of the study population in the two arms by age, gender, body mass index (BMI), social habits, medical comorbidities and mean insertion and withdrawal times. There were no significant differences in baseline characteristics in both arms except for the prevalence of diabetes, which was seen more frequently in bNBI arm (bNBI, *n* = 56 (11.3%) *vs* HD-WLE, *n* = 32 (5.3%). The mean time to reach caecum was similar in both arms; however, the mean withdrawal time was 1.39 min longer in the bNBI arm (*P* \< 0.05).

Adenoma detection rates
-----------------------

A total of 1084 polyps were detected in both arms. The overall mean polyp detection rate per colonoscopy in the bNBI arm was 1.13 and in the HD-WLE arm was 1.02 (*P* = 0.093). Two hundred and sixty subjects in the bNBI arm (52.53%) and 257 in the HD-WLE group (50.29%) had one or more polyp (*P* = 0.479). About two thirds (*n* = 638) of polyps were identified on left side of the colon and 92.8 % (*n* = 1005) of polyps were less than 10mm in size.

The ADR in the bNBI group and HD-WLE group was 37.4% and 39.3% respectively (185 of 495 subjects and 201 of 511 subjects had at least one adenoma) (Table [2](#T2){ref-type="table"}). Table [2](#T2){ref-type="table"} demonstrates the pathological diagnosis of polyps detected in both arms. Sixty one percent (341/561) of polyps in bNBI arm and 62% (326/523) in HD-WLE arm were adenomatous (*P* = 0.425) in nature. ADRs were directly related to withdrawal time in both arms, as shown in Figure [2](#F2){ref-type="fig"}, ADR progressively increased with increasing withdrawal time. A higher number of hyperplastic polyps were identified in bNBI arm than in HD-WLE arm (bNBI, *n* = 178 *vs* HD-WLE, *n* = 136), which was statistically significant (*P* = 0.021). According to logistic regression analysis, withdrawal time (OR = 1.19, 95%CI: 1.15-1.24, *P* \< 0.001), age (OR = 1.03, 95%CI: 1.00-1.05, *P* = 0.032) and male sex (OR = 1.49, 95%CI: 1.11-2.00, *P* = 0.008) were independently associated with an improved ADR when adjusted for differences in baseline variables. When we adjusted for withdrawal time (OR = 1.19, 95%CI: 1.15-1.24, *P* \< 0.001), the use of bNBI was associated with a reduced ADR (OR = 0.69, 95%CI: 0.52-0.92).

###### 

Pathologic diagnosis in both bright narrow band imaging and high definition white light endoscopy *n* (%)

                                                                   **bNBI (*n* = 495)**   **HD-WLE (*n* = 511)**   ***P* value**
  ---------------------------------------------------------------- ---------------------- ------------------------ ---------------
  Adenomas                                                         341                    326                      0.425
  Subjects with adenomas[2](#T2FN2){ref-type="table-fn"} (ADR)     185 (37.4)             201 (39.3)               0.523
  Adenomas per adenoma carrier[1](#T2FN1){ref-type="table-fn"}     1.84                   1.62                     0.129
  Size                                                                                                             
  Subjects with 0-5 mm adenomas[2](#T2FN2){ref-type="table-fn"}    149 (30.1)             162 (31.2)               0.583
  Subjects with 6-9 mm adenomas[2](#T2FN2){ref-type="table-fn"}    52 (10.5)              52 (10.2)                0.864
  Subjects with ≥ 10 mm adenomas[2](#T2FN2){ref-type="table-fn"}   31 (6.3)               31 (6.1)                 0.897
  Adenomas \< 10 mm                                                306                    290                      0.283
  Adenomas 0-5 mm                                                  241                    229                      0.334
  Adenomas 6-9 mm                                                  65                     61                       0.896
  Adenomas ≥ 10 mm                                                 35                     36                       0.837
  Location                                                                                                         
  Right-sided adenomas                                             157                    155                      0.400
  Left-sided adenomas                                              168                    159                      0.797
  Histopathology                                                                                                   
  Carcinomas                                                       3                      5                        0.418
  Tubular                                                          315                    304                      0.343
  Tubulovillious                                                   10                     12                       0.689
  Villious                                                         2                      0                        NA
  Adenomas with high grade dysplasia                               6                      7                        0.992
  Hyperplastic polyps                                              178                    136                      0.020
  Hyperplastic polyps \< 10 mm                                     176                    135                      0.020
  SSA/Ps                                                           13                     7                        0.257
  Subjects with SSA/P, *n* (SSA/P-detection rate in %)             13 (2.6)               6 (1.2)                  0.091
  Inflammatory polyps                                              12                     14                       0.572
  Indeterminate or non-significant                                 16                     15                       0.987
  Not submitted for histologic examinations                        13                     31                       0.010
  Xanthoma                                                         1                      1                        0.961

Mann-Whitney\'s *U* test used;

*χ*^2^ test or Fisher's exact test used as appropriate. HD-WLE: High definition white light endoscopy; bNBI: Bright narrow band imaging.

![Adenoma detection rate *vs* withdrawal time. HD-WLE: High definition white light endoscopy; bNBI: Bright narrow band imaging.](WJGE-9-273-g002){#F2}

Polyp characterisation
----------------------

Nine hundred and thirty-three polyps (86%) from both arms were categorized into various classes with high confidence according to Sano's classification. The other 13.9% (*n* = 151) were classified with low confidence. Among the high confidence polyps, 308 (33%) polyps were Sano type I; 598 (64%) were type II; 20 (2.1%) were type IIIA and 7 (0.75%) were type IIIB.

The Sn, Sp, PPV and NPV in differentiating adenomatous from non-adenomatous polyps of all sizes were 95.7%, 86.5%, 93.9% and 91.0% respectively (Table [3](#T3){ref-type="table"}). The Sn, Sp, PPV and NPV in differentiating an adenoma from cancer were 87.5%, 100%, 100%, and 99.8% respectively (Table [4](#T4){ref-type="table"}). The Sn, Sp, PPV and NPV of bNBI-DF in the characterisation of polyps with 5mm or less in the rectosigmoid region were 94.5%, 95.4%, 94.8% and 93.7% respectively (Table [5](#T5){ref-type="table"}).

###### 

Polyp categorization according to Sano's classification - Hyperplastic/SSA/*P vs* adenoma/cancer

                          **Pathology**   **Total**   
  ----------------------- --------------- ----------- -----
  Sano's classification                               
  I                       245             24          269
  II, IIIa, IIIb          36              555         591
  Total                   281             579         

Sensitivity of predicting adenoma = 95.7% (93.4% to 97.2%); Specificity of predicting adenoma = 86.5% (81.7% to 90.2%); PPV of predicting adenoma = 93.9% (91.7% to 95.6%); NPV of predicting adenoma = 91.0% (86.4% to 94.0%).

###### 

Polyp characterisation according to Sano's classification - Adenoma vs cancer

                          **Pathology**   **Total**   
  ----------------------- --------------- ----------- -----
  Sano's classification                               
  II, IIIa                547             1           548
  IIIb                    0               7           7
  Total                   547             8           

Sensitivity of predicting cancer = 87.5% (47.4% to 99.7%); Specificity of predicting cancer = 100% (99.3% to 100%); PPV of predicting cancer = 100% (59.0% to 100%); NPV of predicting cancer = 99.8% (98.7% to 100%).

###### 

Polyp characterisation based on Sano's classification for polyps in the rectosigmoid region (5 mm or less in size)

                          **Pathology**   **Total**   
  ----------------------- --------------- ----------- -----
  Sano's classification                               
  I                       146             10          156
  II, IIIa, IIIb          7               130         137
  Total                   153             140         

Sensitivity of predicting adenoma = 94.5% (89.1% to 97.3%); Specificity of predicting adenoma = 95.4% (90.6% to 97.8%); PPV of predicting adenoma = 94.8% (89.5% to 97.5%); NPV of predicting adenoma = 93.7% (87.7% to 96.9%).

DISCUSSION
==========

This prospective multicenter randomised study compared two different modalities: HD-WLE and bNBI to assess if there was a difference in ADRs. In addition, bNBI-DF was used to characterise polyps using the Sano's classification. We did not find a statistically significant improvement in ADR with bNBI when compared to HD-WLE. Polyp characterisation was effective with bNBI-DF in differentiating adenomas from hyperplastic polyps in diminutive distal polyps, meeting the second PIVI standard.

The study design was similar to that of Rex and Helbig, who evaluated an earlier version of NBI\[[@B24]\]. Their study represented a single operator experience, in contrast to this study, which involved several academic centers. In a recent tandem study, Leung et al\[[@B25]\] compared bNBI to HD-WLE in colonoscopy. Subjects were submitted to bNBI first and followed by HD-WLE or *vice versa*. The use of bNBI was associated with a higher ADR with a higher number of polyps detected per subject. However, for the HD-WLE group, the older generation 260 series colonoscopes were used. Illumination with 260 series colonoscopes is considerably less sharp when compared to the 190/290 series colonoscopes. Hence, one cannot be certain if the superiority of bNBI in finding adenomas was not a result of a "brighter processor". In another study by Wallace et al\[[@B26]\], average risk subjects presenting for screening were randomised to receive the examination by a standard colonoscope (H180) or a dual focus colonoscope (HQ-190). ADR were similar between both groups (52% *vs* 50%). The NPV for diminutive rectosigmoid polyps were 96 and 97% respectively, which was not too dissimilar to our study.

Multiple randomised studies and a meta-analysis compared ADRs of NBI with conventional colonoscopy. The results have thus far been mixed with very few studies\[[@B27],[@B28]\] demonstrating improved ADRs with NBI. Despite having endoscopists with considerable experience in using NBI and a large sample size, we were unable to demonstrate a statistically significant improvement in ADR. Actually, this study suggests that NBI could actually decrease the ADR if used exclusively for overview of the whole colon during withdrawal. The similar ADRs achieved in this study may be attributed to the fact that improved resolution could be achieved using the same high definition processor for both bNBI and HD-WLE. These findings are not too dissimilar to studies conducted in the past with older generation systems\[[@B29]-[@B31]\].

Previous studies conducted using bNBI to differentiate adenomatous from non-adenomatous lesions demonstrated accuracies ranging from 77% to 93%\[[@B8],[@B32]-[@B36]\]. Sessile serrated adenomas/polyps (SSA/Ps), which endoscopically may resemble hyperplastic polyps but have malignant potential, were detected in 1.8% of all polyps. Previous studies have shown the prevalence of SSAs ranging from 1% to 7%\[[@B37]\], but a more recent study shows that the reported prevalence of SSA/Ps is raising with the years and it can get up to 15.8%\[[@B38]\]. This difference may be due in part to the different prevalence rate in the studied population, which included predominantly a younger Asian cohort. These polyps unfortunately do not fit into any of the available classifications at the time the study was performed.

This study adds strength to the usefulness of bNBI in characterising colonic lesions in real-time. This "endopathology" concept supports the "resect and discard" approach that carries many practical advantages. In a simulation model by Hassan et al\[[@B6]\], this strategy resulted in a substantial economic benefit without any impact on efficacy. Kessler et al\[[@B13]\] demonstrated that endoscopic diagnosis of polyp histology during colonoscopy and forgoing pathologic examination would result in substantial up-front cost savings whilst the downstream consequences of the resulting incorrect surveillance intervals appear to be negligible. bNBI-DF used in this study not only successfully met the second PIVI threshold established by the ASGE but also demonstrated the highest accuracy so far in differentiating adenomas from hyperplastic polyps\[[@B6]\]. More than 85% of polyps were characterised with high confidence and the overall sensitivity and specificity demonstrated was significantly higher than in other studies\[[@B18]\].

This study has some limitations. First, the mean withdrawal time was prolonged in both arms, but particularly in the bNBI's arm (11.23 min *vs* 9.84 min). In a multiple regression model, examination of the colon in the HD-WLE mode was associated with a better ADR. Similar to this study, longer withdrawal times with bNBI were also noted in a meta-analysis by Jin et al\[[@B39]\] as well as by Rex et al\[[@B24]\]. This could be potentially explained by the lack of confidence in assessing the mucosa in an overview mode with bNBI, although endoscopists were experienced with previous versions of the modality. The ADRs in both arms of the study were higher than the target ADR set by the United States Multi-Society Task Force (men \> 25% and women \> 15%)\[[@B40]\]. Longer withdrawal times and high-definition imaging are the possible reasons for the overall higher adenoma detection rates.

In conclusion, ADR was not different between bNBI and HD-WLE. Male sex, larger withdrawal time and older age where positively correlated with ADR. When adjusted for withdrawal time, HD-WLE had higher ADR. With bNBI-DF, 85% of the polyps could be characterised with high confidence, of which more than 95% of them were predicted accurately. The most worthwhile strategy to reduce the risks associated with unwarranted polypectomies and save costs incurred with pathological assessment of polyps could be a "combination strategy" where withdrawal is performed using HD-WLE and polyp characterisation with bNBI-DF.

COMMENTS
========

Background
----------

Colorectal polyps are the precursors of colorectal cancer and their removal through colonoscopy is effective in preventing colorectal cancer. New technologies continuously improve the imaging ability of the colonoscopes. Whether these new technologies effectively differ from each other for detection of polyps is debatable.

Research frontiers
------------------

The development of state-of-the-art endoscopes are not always associated with better results. Technologies that enhance imaging supposedly could improve the detection of polyps. So far, the use of light filters to improve adenoma detection rate (ADR) is not recommended.

Innovations and breakthrough
----------------------------

Improvement in ADR is important as it is inversely correlated with colorectal cancer risk. The improvement of old technologies has been shown beneficial for detection of polyps (*i.e*., HD *vs* non-HD imaging). However, comparison between new technologies is less studied. The authors therefore evaluated the use of two cutting-edge technologies \[high definition white light endoscopy (HD-WLE) and bright narrow band imaging (bNBI)\] to detect colorectal polyps.

Applications
------------

Although virtual chromoendoscopy is useful for characterising polyps, its use for detecting them did not differ from HD-WLE in this study. Therefore, even though there is improvement in the brightness with the new light filter, it is still not recommended as standard of care for screening purposes.

Terminology
-----------

Adenoma detection rate is defined as the percentage of patients that were submitted to colonoscopy and had at least one adenomatous polyp. Narrow band imaging is an optical image-enhanced technology based on specific light wavelengths, which allows enhanced visualisation of vasculature and superficial mucosal surface.

Peer-review
-----------

The authors compared ADR of two different modalities. They found that HD-WLE had higher ADR after adjustment of withdrawal time. bNBI had satisfactory negative predictive value in differentiating adenomatous from non-adenomatous histology in dimunitive polyps, which was above the preservation and incorporation of valuable endoscopic innovation threshold. The paper is well written.
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